Perineural invasion in cutaneous squamous cell carcinoma (cSCC) is associated with an increased risk of local recurrence, nodal metastases, and disease-specific death. Adjuvant radiotherapy has been suggested to mitigate aggressive behavior of cSCC with perineural invasion.1-3 To clarify the utility of adjuvant radiotherapy for cSCC with perineural invasion, we investigated the outcomes of local recurrence, nodal metastases, distant metastases, and disease-free survival of patients treated surgically with or without adjuvant radiotherapy.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Stevenson ML, Criscito MC, Wilken R, et al. Use of Adjuvant Radiotherapy in the Treatment of High-risk Cutaneous Squamous Cell Carcinoma With Perineural Invasion. JAMA Dermatol. Published online July 01, 2020. doi:10.1001/jamadermatol.2020.1984
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: